FindTrial
Sign In

Antibiotic resistance in Acne Vulgaris

Evaluation of antibiogram and biofilm formation of Cutibacterium acnes isolated from acne vulgaris. - EABCA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030458
Enrollment
40
Registered
2021-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: SWAB COLLECTION: Swab will be collected from the acne lesion.(Grade 2 and above). Control Intervention1: Antibiotic susceptibility and Microtitre plate assay for biofilms: Isolates will

Sponsors

Dr Navya Anna Paul
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Patients of age 12 and above who are willing to participate in the study with consent or parental/ guardian consent -After a detailed clinical evaluation, confirmed cases of acne vulgaris -Grade 2 and above.

Exclusion criteria

Exclusion criteria: -Patients who is undergoing treatment with antibiotics â?? topical or systemic. -Patients on other topical medications -Patients on oral retinoids.

Design outcomes

Primary

MeasureTime frame
To isolate and characterize C. acnes from acne vulgaris. 2. To detect ability of biofilm formation by C. acnesTimepoint: 1 year—

Secondary

MeasureTime frame
To compare between biofilm formation and antibiotic resistance of C. acnes isolatesTimepoint: At the end of the study—

Countries

India

Contacts

Public ContactDr Navya Anna Paul

Father Muller Medical College

rameshderma@gmail.com9845084224

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026